ReviewPostepy psychiatrii neurologii2021
Post-stroke alexithymia - a review.
Review in Postepy psychiatrii neurologii, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
- Effects of arabinoxylan on BDNF/TrkB/p-CREB signaling pathway in the prefrontal cortex and intestinal microbiome in post-stroke depressed rats.BMC neuroscience · 2025Article
- Neural Correlates of Alexithymia Based on Electroencephalogram (EEG)-A Mechanistic Review.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The goal of this study is a review of the literature on the role of alexithymia among stroke patients, especially assessing its impact on the process of convalescence, psychiatric comorbidity and clinical outcomes. Views: Organic alexithymia is a common post-stroke complication, which interferes with many aspects of health among stroke survivors, with interleukin-18 having an important role in the appearance and depth of alexithymia. Post-stroke patients suffering from alexithymia are more prone to depression, manifestations of which may differ from the symptoms of this shown by the non-alexithymic post-stroke population. Alexithymia is also the cause of more severe symptoms of stroke itself, as well as more severe symptoms of post-stroke post-traumatic stress disorder. It is often associated with right-hemisphere lesions, but there are findings which show that left brain insult may also be the cause; the explanation is that information transfer from right to left hemisphere causes disturbances in emotional awareness. Conclusions: Alexithymia plays an important role in the health of post-stroke patients. Assessment of the trait should be considered in their population, since it plays an important role in terms of predicting psychiatric comorbidity and severity of stroke complications, which transfers to treatment choice. Further research is required to examine other post-stroke psychiatric comorbidities associated with alexithymia and to closely determine the response of rehabilitation, including pharmacological treatment and psychological therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.